Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling

被引:7
|
作者
Taylor, Rulaiha E. [1 ]
Bhattacharya, Anisha [1 ]
Guo, Grace L. [1 ,2 ,3 ,4 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ USA
[2] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA
[3] Rutgers State Univ, Rutgers Ctr Lipid Res, Piscataway, NJ USA
[4] VA New Jersey Hlth Care Syst, Vet Adm Med Ctr, E Orange, NJ USA
基金
美国国家卫生研究院;
关键词
ARYL-HYDROCARBON RECEPTOR; FATTY LIVER-DISEASE; BREAST-CANCER RISK; NONALCOHOLIC STEATOHEPATITIS; ORGANOCHLORINE PESTICIDES; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PERFLUOROALKYL SULFONATES; ENDOGENOUS BIOMARKERS; EXPRESSION CLONING; OBETICHOLIC ACID;
D O I
10.1124/dmd.121.000388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Maintaining bile acid (BA) homeostasis is important and regulated by BA activated receptors and signaling pathways. Farnesoid X receptor (FXR) and its regulated target networks in both the liver and the intestines are critical in suppressing BA synthesis and promoting BA transport and enterohepatic circulation. In addition, FXR is critical in regulating lipid metabolism and reducing inflammation, processes critical in the development of cholestasis and fatty liver diseases. BAs are modulated by, but also control, gut microflora. Environmental chemical exposure could affect liver disease development. However, the effects and the mechanisms by which environmental chemicals interact with FXR to affect BA homeostasis are only emerging. In this minireview, our focus is to provide evidence from reports that determine the effects of environmental or therapeutic exposure on altering homeostasis and functions of BAs and FXR. Understanding these effects will help to determine liver disease pathogenesis and provide better prevention and treatment in the future. SIGNIFICANCE STATEMENT Environmental chemical exposure significantly contributes to the development of cholestasis and nonalcoholic steatohepatitis (NASH). The impact of exposures on bile acid (BA) signaling and Farnesoid X receptor-mediated gut-liver crosstalk is emerging. However, there is still a huge gap in understanding how these chemicals contribute to the dysregulation of BA homeostasis and how this dysregulation may promote NASH development.
引用
收藏
页码:456 / 467
页数:12
相关论文
共 50 条
  • [41] β-Defensin 1 ls Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids via Farnesoid X Receptor and Constitutive Androstane Receptor
    Klag, Thomas
    Thomas, Maria
    Ehmann, Dirk
    Courth, Lioba
    Mailaender-Sanchez, Daniela
    Weiss, Thomas S.
    Dayoub, Rania
    Abshagen, Kerstin
    Vollmar, Brigitte
    Thasler, Wolfgang E.
    Stange, Eduard F.
    Berg, Christoph P.
    Malek, Nisar P.
    Zanger, Ulrich M.
    Wehkamp, Jan
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [42] Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor
    Singh, Amar Bahadur
    Dong, Bin
    Xu, Yanyong
    Zhang, Yanqiao
    Liu, Jingwen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, 1864 (03): : 358 - 371
  • [43] Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
    Yang, Fan
    Lv, Xi-Ting
    Lin, Xiao-Li
    Wang, Ruo-Hong
    Wang, Shu-Mei
    Wang, Guo-En
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (12) : 1961 - 1971
  • [44] Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
    Xiong, Aizhen
    Lu, Longhui
    Jiang, Kaiyuan
    Wang, Xiaoning
    Chen, Yan
    Wang, Xunjiang
    Zhang, Wei
    Zhuge, Yuzheng
    Huang, Wendong
    Li, Lujin
    Liao, Qi
    Yang, Fan
    Liu, Ping
    Ding, Lili
    Wang, Zhengtao
    Yang, Li
    ARCHIVES OF TOXICOLOGY, 2024, 98 (08) : 2557 - 2576
  • [45] Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice
    Csanaky, Ivan L.
    Lickteig, Andrew J.
    Zhang, Youcai
    Klaassen, Curtis D.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 403
  • [46] Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis
    Li, Hongshan
    Xi, Yingfei
    Xin, Xin
    Tian, Huajie
    Hu, Yiyang
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 124
  • [47] Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice
    Lu, Qian
    Yu, Jingyi
    Xia, Ninglin
    Jin, Ming
    Zhao, Wen
    Fan, Xue
    Zhang, Rongmi
    Wang, Jie
    Jiang, Zhenzhou
    Yu, Qinwei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2025, 406
  • [48] Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids
    Xia, Yunlong
    Xu, Xinyue
    Guo, Yongzhen
    Lin, Chen
    Xu, Xiaoming
    Zhang, Fuyang
    Fan, Miaomiao
    Qi, Tingting
    Li, Congye
    Hu, Guangyu
    Peng, Lu
    Wang, Shan
    Zhang, Ling
    Hai, Chunxu
    Liu, Rui
    Yan, Wenjun
    Tao, Ling
    ADVANCED SCIENCE, 2022, 9 (24)
  • [49] 3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism
    Stefela, Alzbeta
    Kaspar, Miroslav
    Drastik, Martin
    Holas, Ondrej
    Hroch, Milos
    Smutny, Tomas
    Skoda, Josef
    Hutnikova, Miriama
    Pandey, Amit V.
    Micuda, Stanislav
    Kudova, Eva
    Pavek, Petr
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 202
  • [50] Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model
    P. Comeglio
    S. Filippi
    E. Sarchielli
    A. Morelli
    I. Cellai
    C. Corno
    L. Adorini
    G. B. Vannelli
    M. Maggi
    L. Vignozzi
    Journal of Endocrinological Investigation, 2019, 42 : 951 - 965